GEN Magazine Supplement
April 2021 Vol. 41, No. 4
GEN has assembled a supplement on cell and gene therapies that addresses a range of topics: the production of viral vectors, the use of analytical tools to demonstrate regulatory compliance, the development of CRISPR-based therapeutics, and the combination of 3D-bioprinting and cell-based precision medicine. The supplement also includes sponsored content from three of the major players advancing these revolutionary approaches.